Lubberman F, Gelderblom H, Hamberg P, et al. A reduced pazopanib dose with food: Is it more patient-friendly and does it reduce drug costs? ASCO Annual Meeting 2019, abstract 4564.
Langetermijnresultaten van SABR bij operabel stadium I NSCLC
dec 2021 | Chirurgie, Longoncologie, Radiotherapie